Joy Birkelbach

Joy Birkelbach is a Postdoctoral Researcher in the Department of Microbial Natural Products at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a leading research institution focused on pharmaceutical sciences. Holding a PhD in Pharmacy, she is actively engaged in cutting-edge research on natural products as sources for novel antibiotics, with a particular emphasis on combating antimicrobial resistance in Gram-negative pathogens. Her work is highly cited and reflects a strong commitment to addressing one of the most pressing global health challenges.

Her educational background includes:

• PhD in Pharmacy

Dr. Birkelbach's research interests center on the discovery and development of bioactive natural products from microbial sources, especially myxobacteria. She specializes in the isolation and structure elucidation of novel compounds using advanced techniques such as NMR spectroscopy, GC-MS, and LC-MS. Her work aims to identify new antibacterial agents that can overcome existing resistance mechanisms, with a strong focus on Gram-negative bacteria which are particularly challenging to treat. She also investigates the biosynthesis and genetic engineering of natural products to enhance their therapeutic potential.

Analysis of her recent publications (2022-2024) reveals a consistent trajectory in antibiotic discovery, with significant contributions in the engineering of darobactin derivatives for improved potency against Gram-negative pathogens, the exploration of new bacterial families (such as Pendulisporaceae) for specialized metabolism, and the characterization of cytotoxic compounds like disorazoles and ajudazols. Her research integrates microbial diversity, genomic analysis, and chemical synthesis to develop next-generation antibacterials and anticancer agents.

Dr. Birkelbach is an active member of Rolf Müller's research group at HIPS, where she collaborates with a multidisciplinary team of microbiologists, chemists, and pharmacologists. This collaborative environment fosters innovation in natural product research and accelerates the translation of discoveries into potential therapeutics.